Beyond recurrence detection : treating the forgotten menopause in endometrial cancer survivors
Source
European journal of obstetrics and gynecology and reproductive biology - ISSN 0301-2115-321 (2026) p. 1-6
NSGO-FANDANGO/ENGOT-EN1 : a randomized phase II study of first-line combination chemotherapy with nintedanib/placebo in advanced/ recurrent endometrial cancer
Source
Gynecologic oncology - ISSN 0090-8258-199 (2025) p. 79-87
Is switching to T-DM1 still justified in HER2-negative residual breast cancer after neoadjuvant systemic therapy?
Source
The Breast - ISSN 0960-9776-81 (2025) p. 1-2
Exploring immunological dynamics in breast cancer during systemic therapy
Source
Antwerp, University of Antwerp, Faculty of Medicine and Health Sciences, 2025,155 p.
Tumor microenvironment modulation by tumor-associated macrophages : implications for neoadjuvant chemotherapy response in breast cancer
Source
Breast cancer : targets and therapy - ISSN 1179-1314-17 (2025) p. 211-224